Impact of Sarcoidosis on In-Hospital Outcomes Among Patients with Atrial Fibrillation: A Nationwide Readmissions Database Analysis
Author Type(s)
Resident/Fellow
Document Type
Article
Publication Date
3-1-2024
DOI
10.19102/icrm.2024.15035
Journal Title
The Journal of Innovations in Cardiac Rhythm Management
Department
Medicine
Abstract
Sarcoidosis is a disease that involves multiple organs, including the cardiovascular system. While cardiac sarcoidosis has been increasingly recognized, the impact of sarcoidosis on atrial fibrillation (AF) is not well established. This study aimed to analyze the impact of sarcoidosis on in-hospital outcomes among patients who were admitted for a primary diagnosis of AF. Using the all-payer, nationally representative Nationwide Readmissions Database, our study included patients aged ≥18 years who were admitted for AF between 2017-2020. We stratified the cohort into two groups depending on the presence of sarcoidosis diagnosis. The in-hospital outcomes were assessed between the two groups via propensity score analysis. A total of 1031 (0.27%) AF patients with sarcoidosis and 387,380 (99.73%) AF patients without sarcoidosis were identified in our analysis. Our propensity score analysis of 1031 (50%) patients with AF and sarcoidosis and 1031 (50%) patients with AF but without sarcoidosis revealed comparable outcomes in early mortality (1.55% vs. 1.55%,
Recommended Citation
Tan, M., Ang, Q., Yeo, Y., San, B., Ibrahim, R., Ng, S., Tan, J., Walia, J., Suleiman, A., & Correia, J. (2024). Impact of Sarcoidosis on In-Hospital Outcomes Among Patients with Atrial Fibrillation: A Nationwide Readmissions Database Analysis. The Journal of Innovations in Cardiac Rhythm Management, 15 (3), 5782-5785. https://doi.org/10.19102/icrm.2024.15035
